ArticleThe Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi2025
Association between Gastroparesis and the Pancreatic Cancer Risk and In-Hospital Mortality: A Nationwide Analysis from the United States.
Article in The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Aims: Pancreatic cancer is a highly lethal malignancy often diagnosed at an advanced stage. Gastroparesis, marked by delayed gastric emptying, may be a potential risk factor or early indicator. Despite this, little is known about the association between gastroparesis and pancreatic cancer. Methods: This retrospective cohort study analyzed the data from the Nationwide Inpatient Sample (2016-2021), encompassing 207,629,866 hospitalizations. Adult hospitalizations with a diagnosis of pancreatic cancer, and with or without a diagnosis of gastroparesis, were identified using International Classification of Diseases, Tenth Revision codes. Multivariable logistic regression was used to assess the association between gastroparesis and pancreatic cancer, adjusting for demographic and clinical variables. Results: Among 603,075 hospitalizations of patients with pancreatic cancer, 6,095 (1.0%) had gastroparesis compared to 0.7% of the hospitalizations with non-pancreatic cancer patients (p<0.001). Among the pancreatic cancer patients, those with gastroparesis were younger (mean age 65.55±11.61 vs. 68.46±11.44 years; p<0.001) and more likely to be female (54.2% vs. 45.8%; p<0.001). Patients with gastroparesis experienced longer hospital stays (8.48±8.30 days vs. 5.70±5.70 days; p<0.001) and higher total charges ($86,385.90±$105,352.67 vs. $63,250.12±$78,421.65; p<0.001). Gastroparesis was linked to an increased odds of pancreatic cancer (odds ratio [OR] 1.12, 95% confidence interval [CI] 1.08-1.16) and reduced in-hospital mortality (OR 0.51, 95% CI 0.44-0.58; p<0.001). Conclusions: Gastroparesis is associated with higher odds of pancreatic cancer but a lower risk of in-hospital mortality from pancreatic cancer hospitalizations. Although causal and temporal relationships cannot be established because of the cross-sectional nature of the dataset.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.